LUCD - Lucid Diagnostics Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
565
377
500
0
0
Cost of Revenue
2,437
3,614
585
-
-
Gross Profit
-1,872
-3,237
-85
-
-
Operating Expenses
Research Development
12,506
11,466
9,296
5,443
3,462
Selling General and Administrative
36,962
39,819
18,038
2,837
958.722
Total Operating Expenses
50,612
52,934
27,334
8,280
4,421
Operating Income or Loss
-52,484
-56,171
-27,419
-8,280
-4,421
Interest Expense
65
0
659
-
-
Income Before Tax
-52,549
-56,171
-28,078
-8,280
-4,421
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-52,549
-56,171
-28,078
-8,280
-4,421
Net Income
-52,549
-56,171
-28,078
-8,280
-4,421
Net Income available to common shareholders
-52,549
-56,171
-28,078
-8,280
-4,421
Basic EPS
-
-
-1.51
-0.22
-0.12
Diluted EPS
-
-
-1.51
-0.22
-0.12
Basic Average Shares
-
-
18,604
36,992
36,992
Diluted Average Shares
-
-
18,604
36,992
36,992
EBITDA
-
-54,235
-27,415
-8,280
-4,421